Estimation of clinical trial success rates and related parameters
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abrantes-Metz, 2005, Pharmaceutical development phases: a duration analysis., Journal of Pharmaceutical Finance, Economics and Policy, 14, 19, 10.1300/J371v14n04_03
Danzon, 2005, Productivity in pharmaceutical–biotechnology R&D: the role of experience and alliances., Journal of Health Economics, 24, 317, 10.1016/j.jhealeco.2004.09.006
DiMasi, 2010, Trends in risks associated with new drug development: success rates for investigational drugs., Clinical Pharmacology and Therapeutics, 87, 272, 10.1038/clpt.2009.295
Hay, 2014, Clinical development success rates for investigational drugs., Nature Biotechnology, 32, 40, 10.1038/nbt.2786
Malec, 2014, Nonparametric kernel density estimation near the boundary., Computational Statistics & Data Analysis, 72, 57, 10.1016/j.csda.2013.10.023
Martin, 2017, Trial watch: clinical trial cycle times continue to increase despite industry efforts., Nature Reviews Drug Discovery, 16, 157, 10.1038/nrd.2017.21
Root, 2014, Biogen Idec Moves Aggressively, Advances Alzheimer Drug into Phase 3.
Smietana, 2016, Trends in clinical success rates., Nature Reviews Drug Discovery, 15, 379, 10.1038/nrd.2016.85
Thomas, 2016, Clinical Development Success Rates 2006–2015.
2016, Novel Drugs Summary 2015